Microrna In Disease Regulation
48 researchers across 6 institutions
Researchers investigate the roles of microRNAs (miRNAs) in biological processes and disease development. This work explores how small RNA molecules regulate gene expression at the post-transcriptional level and how their dysregulation contributes to various pathologies, including cancer, cardiovascular disease, and neurological disorders. Studies employ molecular biology techniques, genomics, and bioinformatics to identify and characterize miRNAs involved in cellular differentiation, proliferation, apoptosis, and immune responses. Investigations also focus on the potential of miRNAs as biomarkers for early disease detection and as therapeutic targets for novel treatment strategies.
This research has implications for Arkansas's public health, particularly concerning the prevalence of chronic diseases. Understanding miRNA involvement in conditions like cancer and heart disease can inform the development of diagnostic tools and treatments tailored to the state's demographics. Furthermore, insights into miRNA function may contribute to the state's growing biosciences sector, fostering innovation in biotechnology and pharmaceutical development.
This area of study intersects with cancer biology, molecular mechanisms, pharmacology, and cardiovascular research. Engagement spans multiple Arkansas institutions, with researchers contributing expertise from diverse backgrounds to address complex biological questions.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| Yong Zhu | UAMS | 41 | 5,411 | Grant PI High Impact | |
| Takehiro Nakamura | UAMS | 41 | 5,817 | ||
| Seong Wook Kang | University of Arkansas | 35 | 4,848 | High Impact | |
| Ruby Charak | UAMS | 25 | 2,098 | ||
| George Hammons | NCTR | 24 | 2,037 | ||
| Lu Dai | UAMS | 23 | 1,687 | Grant PI High Impact | |
| Pritmohinder S. Gill | UAMS | 21 | 2,197 | High Impact | |
| Ryan M. Allen | UAMS | 20 | 2,253 | High Impact | |
| Valentina K. Todorova | UAMS | 18 | 805 | ||
| Vikrant Vijay | NCTR | 16 | 1,193 | ||
| Sandra Stotsky | University of Arkansas | 15 | 2,744 | ||
| Shahzad Bhatti | UAMS | 15 | 687 | ||
| Neha S. Dole | UAMS | 14 | 608 | Grant PI | |
| Shan Zhao | University of Arkansas | 13 | 764 | ||
| Hoda A. Hagrass | UAMS | 12 | 506 | ||
| Bridgett Knox | NCTR | 12 | 416 | ||
| Subramaniam Ponnappan | UAMS | 11 | 580 | ||
| Haixia Lin | UAMS | 11 | 369 | ||
| Haihong Zhang | UAMS | 11 | 440 | ||
| Graham M. Strub | UAMS | 10 | 3,282 |
Related Research Areas
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 Harvard University 2,555
- 2 The University of Texas MD Anderson Cancer Center 1,707
- 3 The Ohio State University 1,360
- 4 National Institutes of Health 1,190
- 5 Johns Hopkins University 1,164
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Microrna In Disease Regulation.